Alferon N interferon alfa-n3 regulatory update

Hemispherx Biopharma said GP Pharm submitted a regulatory application in Argentina for Hemispherx's Alferon N interferon alfa-n3 to treat genital warts. Late last year, GP Pharm exercised an option fo...